Transition Therapeutics Shares Up 23.4% Since SmarTrend's Buy Recommendation (TTHI)
Comtex SmarTrend(R) - Tue Dec 23, 5:03PM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 7 months, Transition Therapeutics has returned 23.40% as of today's recent price of $6.83.
TTHI: 6.85 (+0.02)
Shares of TTHI Up 16.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Dec 16, 11:10AM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 16.62% as of today's recent price of $6.46.
TTHI: 6.85 (+0.02)
Direction of Market Influences: Analyst Notes on Dixie, Goodyear, Pantry, Transition Therapeutics and Turtle Beach
PR Newswire - Mon Dec 15, 11:13AM CST
Moments ago, Realtime Equities released new analyst updates concerning several important developing situations. Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
TTHI: 6.85 (+0.02)
Is Transition Therapeutics (TTHI) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 7:31AM CST
Transition Therapeutics is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
TTHI: 6.85 (+0.02)
Transition Therapeutics Has Returned 16.0% Since SmarTrend Recommendation (TTHI)
Comtex SmarTrend(R) - Tue Dec 09, 9:30AM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 15.99% as of today's recent price of $6.42.
TTHI: 6.85 (+0.02)
Transition Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference
PR Newswire - Mon Dec 08, 3:35PM CST
Transition Therapeutics Inc. ("Transition" or the "Company"
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)
Transition Therapeutics Up 12.2% Since SmarTrend Uptrend Call (TTHI)
Comtex SmarTrend(R) - Mon Dec 01, 5:08PM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 12.20% as of today's recent price of $6.21.
TTHI: 6.85 (+0.02)
Transition Therapeutics Shares Up 16.0% Since SmarTrend's Buy Recommendation (TTHI)
Comtex SmarTrend(R) - Mon Nov 24, 10:51AM CST
SmarTrend identified an Uptrend for Transition Therapeutics (NASDAQ:TTHI) on June 10th, 2014 at $5.54. In approximately 6 months, Transition Therapeutics has returned 15.99% as of today's recent price of $6.42.
TTHI: 6.85 (+0.02)
Transition Therapeutics' ELND005 Showed No Prolongation of QT Interval
PR Newswire - Mon Nov 24, 5:01AM CST
Transition Therapeutics Inc. ("Transition" or the "Company"
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)
Transition neuropsychiatric drug candidate safe in Phase 2 Down syndrome trial
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 9:55AM CST
TTHI: 6.85 (+0.02)
Transition Therapeutics Announces Results from ELND005 Clinical Study in Adults with Down Syndrome
PR Newswire - Thu Nov 20, 5:01AM CST
Transition Therapeutics Inc. ("Transition" or the "Company"
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)
Transition Therapeutics EPS of -$0.45
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:45PM CST
TTHI: 6.85 (+0.02)
Transition Therapeutics Announces First Quarter Fiscal 2015 Financial Results
PR Newswire - Wed Nov 12, 3:01PM CST
Transition Therapeutics Inc. ("Transition" or the "Company"
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)
Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2015 Financial Results on Wednesday, November 12th, at 4:30 P.M. EST
CNW Group - Mon Nov 10, 5:01AM CST
Transition Therapeutics Inc. ("Transition" or the "Company"
TTH.TO: 8.08 (+0.09), TTHI: 6.85 (+0.02)